Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market dynamics of the Gallbladder Treatment industry are shaped by a combination of medical, demographic, and lifestyle factors, influencing the demand for effective treatment options. Gallbladder diseases like gallstones and inflammation is widely common swallowing of the globe perhaps because people may consume unhealthy diets, obesity being one of the factors as well as having family history of the disease. This demand is driven mainly by a growth in the number of gallbladder diseases, which has generated high demand for both surgical and non-surgical solutions.
Laparoscopic surgeries, notably cholecystectomy, are the main GABT procedures available in this market. Today this laparoscopic approach to cholecystectomy which comes in gallbladder removal has broke the new ground in treatment of different gallbladder pathologies. Technological innovations in the field of surgical techniques delivers more safety and efficiency driving the market growth and providing better opportunities for patients. Furthermore, the development and introduction of minimally invasive techniques that have the ability to perform less aggressive operations with quicker recovery and no post-op complications leads to a change of market value chains patterns.
Non-surgical solutions are the other methods applied for gallbladder disorders, which are medications and modifications in lifestyle as well, and these play an important market role in terms of dynamics. Research and development become a priority for pharmaceutical companies heading towards the development of drugs aimed at either dissolving gallstone organisms or getting rid of the symptoms which are associated with gallbladder dysfunction Dietary changes, weight management, among other lifestyle interventions, become more popular as the superaltern therapeutic measures for treatment of every disease. The market agrees with an increasing tendency to focus on holistic solutions in the sphere of gallbladder provenance, which implies that more comprehensive standards of patient care are needed at last.
Demography-related components of the high-aging population contribute as one of the driving force of gallbladder treatment market growth. As the individual gets older, the likelihood of such gallbladder-linked diseases gropes in the nostrils. Apart from this, it is worthwhile to mention underlying health problems like lifestyle factors including sedentary behavior and unhealthy food habits as a critical factor in the development of gallstones which increases the risk of developing this problem. The aging of demographic and the of lifestyle generate a rise of both preventive and therapeutic measures that in turn becomes a sort of the market's total which is a factor of rapid growth
Medical policies and healthcare facilities, on the other hand, they also influence the market frivolities of this Gallbladder Treatment. All around the globe, governments by means of preventive care and early detection schemes for gallstone problems are channeling their resources into healthcare innovations and development. Attempts to ameliorate financial diseases associated with cholecystectomies and other cholecystic ailments are a determining factor that regulate the landscape and promote the progress of research and development in this area. The distribution of health is uneven worldwide, the shortage of gallbladder treatments and the easy access to them become factors that influence the regional structure of supply and demand.
Competitive situation in the market of Gallbladder Treatment is determined by the presence of different types of medical device companies, drug producers, and healthcare organizations which are focusing on R&D in order to develop many treatment procedures. The plus sides of gallbladder treatment development include the fact they are presenting the experiments that could lead to positive results while the obstacles that could stop the progress include the risk of the postoperative complications and the need for effective non-surgical alternatives.
Patient education and awareness are crucial in addressing these challenges, promoting preventive measures, and ensuring informed decision-making. Moreover, disparities in healthcare access and the economic burden associated with gallbladder disorders underscore the importance of holistic approaches to patient care and healthcare policy.
Gallbladder Treatment Market Highlights:
Global Gallbladder Treatment Market Overview
The Gallbladder Treatment Market Size was valued at USD 16.35 Billion in 2023. The Global Gallbladder Treatment industry is projected to grow from USD 17.52 Billion in 2024 to USD 30.32 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.92% during the forecast period (2024 - 2032). The gall bladder is a small pear-shaped located underneath the liver. Its main function is to store the bile produced by liver and pass it along through a duct that empties into the small intestine. Gall bladder diseases affect a large number of people in the world. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013 and they resulted in 106,000 deaths.
In April 2024, Madrigal Pharmaceuticals Inc., a biopharmaceutical company focused on providing novel therapies for non-alcoholic steatohepatitis (NASH), announced that resmethrin is now commercially available in the U.S., by brand name Rezdiffra. Rezdiffra is part of an overall treatment plan when combined with a diet and exercise program for adults having non-cirrhotic NASH who have medium-to-severe liver fibrosis consistent with stages F2 through F3 fibrosis. Future authorization depends on confirmation of clinical advantage according to ongoing confirmatory studies.
Eli Lilly and Company’s made Zepbound™ (tripeptide) injection has gotten approval from the U.S. Food and Drug Administration. The first ever anti-obesity drug to target the hormonal GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon like peptide-1). Zepbound may be administered to obese people with a body mass index of 30kg/m2 and above, or overweight individuals with a BMI of 27 kg/m2 and over who also have hypertension, dyslipidemia, type II diabetes mellitus, obstructive sleep apnea or cardiovascular disease. It should be used together with reduced-calorie meals and increased physical exercise. Apart from having no studies conducted on individuals who have previously experienced pancreatitis or severe gastrointestinal diseases such as severe gastroparesis, Zepbound should not coexist with any other tripeptide products or GLP-1 receptor agonists.
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) and Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the closing of the recently disclosed acquisition of Travere’s bile acid product portfolio by Mirum including their medications Cholbam® (cholic acid) and Chenodal® (chenodiol), that are used for rare diseases in high-need settings. Upon completion of the asset purchase, Mirum paid Travere $210 million upfront, which could result in an additional $235 million in sales-based milestones.
Gallbladder Treatment Market Trends
The major driving factors for the growth of the market are increasing geriatric population, increasing prevalence rate of various gallbladder diseases, and introduction & adoption of advanced diagnostic treatment options. Moreover, increasing awareness of the diseases, rising healthcare expenditure, and rising demand from emerging markets of Asia have fuelled the market growth. However, pain and complications during surgery and asymptomatic nature of gallstones may slow the growth of the market. American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Gallbladder Treatment Market Segment Insights
Global gall bladder treatment market has been segmented on the basis of disease indications, diagnosis, treatment and end users.
Gallbladder Treatment Disease Indications Insights
On the basis of disease indications the market is segmented as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps, gall bladder cancer.
Gallbladder Treatment diagnosis Insights
On the basis of diagnosis the market is categorized as ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy and others.
Gallbladder Treatment Insights
On the basis of treatment the market is segmented into surgery, and drugs and on the basis of end users the market is divided into hospitals & gynecology clinics, academic & research centers and others.
Key Findings
- Ultrasound segment accounts for the largest market share in the global gall bladder treatment market while Computerized tomography (CT) segment is projected to grow at a CAGR of 8.3% during the forecast period from 2022 – 2030.
- Surgery segment accounts for the largest market share in the global gall bladder treatment market by Treatment, this segment is expected to reach USD 28,563.7 Million in 2030
Gallbladder Treatment Regional Insights
Considering the global scenario of the market, North America dominates the global gall bladder treatment market owing to the presence of huge population suffering from gall bladder diseases. US holds the largest market share in North America gall bladder treatment market. In developed countries, 10–15% of adults have gallstones. Europe has the second largest market for the gall bladder treatment which is followed by Asia Pacific. Presence of well-developed healthcare sector and high healthcare expenditure, the gall bladder treatment market in Europe is growing at a CAGR of 6.8%. Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, presence of huge population, rising healthcare expenditure and government support for research & development. Asia Pacific gall bladder treatment market is expected to grow at a CAGR of 7.0% during the forecasted period. The Middle East & Africa is expected to have limited growth.
Key players for global gall bladder treatment market
Some of the major players in this market are: Boston Scientific Corporation
- Intuitive Surgical
- C. R. Bard, Inc.
- Dornier MedTech
- Koninklijke Philips N.V.
- B. Braun Melsungen AG
- Sanofi
The report for Global Gall Bladder Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Intended Audience
- Gall Bladder Products Manufacturers
- Gall Bladder Products Providers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
